Search

Your search keyword '"Manabe, O"' showing total 130 results

Search Constraints

Start Over You searched for: Author "Manabe, O" Remove constraint Author: "Manabe, O" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
130 results on '"Manabe, O"'

Search Results

1. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

10. Poster Session 2 : Monday 4 May 2015, 08

11. Poster Session 2: Monday 4 May 2015, 08:00-18:00 * Room: Poster Area

12. P307 Efficacy and adverse effects of strict pretest preparation for 18F-FDG PET/CT for assessment of cardiac sarcoidosis.

13. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

14. Cardiovascular imaging in cardio-oncology.

16. Examination of iatrogenic FDG accumulation after COVID-19 vaccination.

17. Current status and perspectives of nuclear cardiology.

18. Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects.

19. Ischaemia in the right ventricle and left ventricle, and rheumatoid myalgia incidentally found in a lung cancer patient treated with immune checkpoint inhibitors: a case report with 18F-fluorodeoxyglucose-positron emission tomography/computed tomography imaging.

20. Serial Quantitative Assessment of Myocardial Blood Flow With 13 N-Ammonia Positron Emission Tomography in a Symptomatic Patient With Tachycardia-Induced Cardiomyopathy.

21. Interaction of impaired myocardial flow reserve and extent of myocardial ischemia assessed using 13 N-ammonia positron emission tomography imaging on adverse cardiovascular outcomes.

22. Diagnostic values of delayed additional FDG PET/CT scan in the evaluation of cardiac sarcoidosis.

25. Comparison of 1-h with 3-h planar 99m Tc-pyrophosphate scintigraphy in patients with suspected transthyretin cardiac amyloidosis using SPECT as a reference standard.

30. Combining the Tumor Contact Length and Apparent Diffusion Coefficient Better Predicts Extraprostatic Extension of Prostate Cancer with Capsular Abutment: A 3 Tesla MR Imaging Study.

31. Editorial for "Diagnostic and Prognostic Value of Cardiac Magnetic Resonance Strain in Suspected Myocarditis With Preserved LV-EF: A Comparison Between Patients With Negative and Positive Late Gadolinium Enhancement Findings".

32. Underdiagnosis of cardiac sarcoidosis by ECG and echocardiography in cases of extracardiac sarcoidosis.

35. Clinical Applications of 4D Flow MR Imaging in Aortic Valvular and Congenital Heart Disease.

38. Advances in Diagnostic Imaging for Cardiac Sarcoidosis.

39. 18 F-FMISO PET/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis.

40. Quantification of myocardial blood flow by CZT-SPECT with motion correction and comparison with 15 O-water PET.

41. The rate of myocardial perfusion recovery after steroid therapy and its implication for cardiac events in cardiac sarcoidosis and primarily preserved left ventricular ejection fraction.

42. What is this image? 2021 image 1 result : A rare case of right ventricular metastasis in renal cell carcinoma detected by thallium-201 scintigraphy.

43. Short-term repeatability of myocardial blood flow using 82 Rb PET/CT: The effect of arterial input function position and motion correction.

44. The Role of Multimodality Imaging in Cardiac Sarcoidosis.

45. Elevated serum endothelin-1 is an independent predictor of coronary microvascular dysfunction in non-obstructive territories in patients with coronary artery disease.

48. Effects of Repeated 131 I- Meta- Iodobenzylguanidine Radiotherapy on Tumor Size and Tumor Metabolic Activity in Patients with Metastatic Neuroendocrine Tumors.

49. Texture analysis of delayed contrast-enhanced computed tomography to diagnose cardiac sarcoidosis.

50. A Preliminary Study to Use SUVmax of FDG PET-CT as an Identifier of Lesion for Artificial Intelligence.

Catalog

Books, media, physical & digital resources